1. Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides;O’Donoghue;J. Nucl. Med.,1995
2. A pragmatic perspective on molecular targeted radionuclide therapy;Larson;J. Nucl. Med.,2005
3. Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: Correlative MicroPET and MRI;Palm;J. Nucl. Med.,2003
4. Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software;Sgouros;J. Nucl. Med.,2004
5. The impact of PET and SPECT on dosimetry for targeted radionuclide therapy;Flux;Z. Med. Phys.,2006